Total Payments
$26,107
2024 Payments
$143.06
Companies
14
Transactions
46
Payment Breakdown by Category
Consulting$17,334 (66.4%)
Other$3,515 (13.5%)
Travel$3,028 (11.6%)
Food & Beverage$2,229 (8.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $17,334 | 5 | 66.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,515 | 1 | 13.5% |
| Travel and Lodging | $3,028 | 9 | 11.6% |
| Food and Beverage | $2,229 | 31 | 8.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $11,185 | 13 | $0 (2022) |
| PFIZER INC. | $5,861 | 9 | $0 (2023) |
| Global Blood Therapeutics, Inc. | $4,514 | 4 | $0 (2022) |
| Vertex Pharmaceuticals Incorporated | $3,395 | 1 | $0 (2022) |
| Agios Pharmaceuticals, Inc. | $428.41 | 6 | $0 (2024) |
| Novo Nordisk Inc | $171.56 | 2 | $0 (2024) |
| Emmaus Medical, Inc. | $171.18 | 3 | $0 (2023) |
| Terumo BCT, Inc. | $103.03 | 1 | $0 (2019) |
| Jazz Pharmaceuticals Inc. | $80.70 | 1 | $0 (2017) |
| United Therapeutics Corporation | $69.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $143.06 | 2 | Novo Nordisk Inc ($123.77) |
| 2023 | $6,460 | 16 | PFIZER INC. ($5,861) |
| 2022 | $7,985 | 5 | Global Blood Therapeutics, Inc. ($4,502) |
| 2021 | $1,940 | 3 | Novartis Pharmaceuticals Corporation ($1,928) |
| 2019 | $328.81 | 7 | Terumo BCT, Inc. ($103.03) |
| 2018 | $9,136 | 10 | Novartis Pharmaceuticals Corporation ($9,099) |
| 2017 | $113.96 | 3 | Jazz Pharmaceuticals Inc. ($80.70) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/23/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Travel and Lodging | Cash or cash equivalent | $19.29 | General |
| Category: Genetically Defined Disease | ||||||
| 06/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $123.77 | General |
| 12/07/2023 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $124.43 | General |
| Category: Genetically Defined Disease | ||||||
| 12/07/2023 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $57.75 | General |
| Category: Genetically Defined Disease | ||||||
| 12/07/2023 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $44.60 | General |
| Category: Genetically Defined Disease | ||||||
| 09/14/2023 | PFIZER INC. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,515.00 | General |
| Category: HEMATOLOGY | ||||||
| 09/13/2023 | Emmaus Medical, Inc. | Endari (Drug) | Food and Beverage | In-kind items and services | $142.75 | General |
| Category: Sickle Cell | ||||||
| 08/24/2023 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $148.08 | General |
| Category: Genetically Defined Disease | ||||||
| 08/23/2023 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $34.26 | General |
| Category: Genetically Defined Disease | ||||||
| 08/19/2023 | PFIZER INC. | OXBRYTA (Drug) | Travel and Lodging | In-kind items and services | $544.68 | General |
| Category: HEMATOLOGY | ||||||
| 08/19/2023 | PFIZER INC. | OXBRYTA (Drug) | Travel and Lodging | In-kind items and services | $528.22 | General |
| Category: HEMATOLOGY | ||||||
| 08/19/2023 | PFIZER INC. | OXBRYTA (Drug) | Travel and Lodging | In-kind items and services | $528.22 | General |
| Category: HEMATOLOGY | ||||||
| 08/19/2023 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $467.88 | General |
| Category: HEMATOLOGY | ||||||
| 08/19/2023 | PFIZER INC. | OXBRYTA (Drug) | Travel and Lodging | In-kind items and services | $231.76 | General |
| Category: HEMATOLOGY | ||||||
| 08/01/2023 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $7.12 | General |
| Category: HEMATOLOGY | ||||||
| 06/26/2023 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: HEMATOLOGY | ||||||
| 05/09/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $47.79 | General |
| 03/02/2023 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: HEMATOLOGY | ||||||
| 09/07/2022 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $3,395.00 | General |
| 07/12/2022 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Food and Beverage | In-kind items and services | $87.85 | General |
| Category: HEMATOLOGY | ||||||
| 05/19/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,242.06 | General |
| Category: Sickle Cell Disease | ||||||
| 05/19/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,242.06 | General |
| Category: Sickle Cell Disease | ||||||
| 01/24/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Sickle Cell Disease | ||||||
| 12/13/2021 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $98.45 | General |
| 11/12/2021 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Consulting Fee | Cash or cash equivalent | $1,830.00 | General |
| Category: HEMATOLOGY | ||||||
About Dr. Elna Saah, MD
Dr. Elna Saah, MD is a Pediatric Hematology-Oncology healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316042617.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elna Saah, MD has received a total of $26,107 in payments from pharmaceutical and medical device companies, with $143.06 received in 2024. These payments were reported across 46 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($17,334).
Ad
Practice Information
- Specialty Pediatric Hematology-Oncology
- Other Specialties Hematology & Oncology
- Location Birmingham, AL
- Active Since 09/13/2006
- Last Updated 10/22/2025
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1316042617
Products in Payments
- OXBRYTA (Drug) $10,374
- CRIZANLIZUMAB (Biological) $9,099
- ADAKVEO (Biological) $1,918
- PYRUKYND (Drug) $428.41
- Endari (Drug) $171.18
- Spectra Optia Apheresis System (Device) $103.03
- Erwinaze (Drug) $80.70
- ORENITRAM (Drug) $69.00
- HEMLIBRA (Biological) $68.13
- PROMACTA (Drug) $53.42
- Gamifant (Drug) $23.80
- Kovaltry (Drug) $19.35
- JADENU (Drug) $15.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Birmingham
Julie Kanter Washko, Md, MD
Pediatric Hematology-Oncology — Payments: $358,287
Pediatric Hematology-Oncology $358,287
Todd Cooper, D.o, D.O
Pediatric Hematology-Oncology — Payments: $188,792
Pediatric Hematology-Oncology $188,792
Frederick Goldman, Md, MD
Pediatric Hematology-Oncology — Payments: $123,247
Pediatric Hematology-Oncology $123,247
Dr. Jeffrey Lebensburger, Do, DO
Pediatric Hematology-Oncology — Payments: $64,513
Pediatric Hematology-Oncology $64,513
Hope Wilson, Md, MD
Pediatric Hematology-Oncology — Payments: $9,794
Pediatric Hematology-Oncology $9,794
Joseph Chewning, M.d, M.D
Pediatric Hematology-Oncology — Payments: $6,081
Pediatric Hematology-Oncology $6,081